These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17442585)

  • 21. Distribution of androgen receptor in rat ovarian follicles undergoing atresia at the beginning of pregnancy.
    Szołtys M; Słomczyńska M; Duda M; Sakiewicz A; Otak A
    Acta Histochem; 2005; 107(5):357-64. PubMed ID: 16256176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The androgen receptor in health and disease.
    Matsumoto T; Sakari M; Okada M; Yokoyama A; Takahashi S; Kouzmenko A; Kato S
    Annu Rev Physiol; 2013; 75():201-24. PubMed ID: 23157556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS.
    Diamanti-Kandarakis E; Papailiou J; Palimeri S
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():198-204. PubMed ID: 16641860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen actions in the ovary: balance is key.
    Prizant H; Gleicher N; Sen A
    J Endocrinol; 2014 Sep; 222(3):R141-51. PubMed ID: 25037707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicle dynamics and anovulation in polycystic ovary syndrome.
    Franks S; Stark J; Hardy K
    Hum Reprod Update; 2008; 14(4):367-78. PubMed ID: 18499708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
    Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgens and the skeleton.
    Lindberg MK; Vandenput L; Movèrare Skrtic S; Vanderschueren D; Boonen S; Bouillon R; Ohlsson C
    Minerva Endocrinol; 2005 Mar; 30(1):15-25. PubMed ID: 15877010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of androgens in ovarian health and disease.
    Lebbe M; Woodruff TK
    Mol Hum Reprod; 2013 Dec; 19(12):828-37. PubMed ID: 24026057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor alpha gene polymorphisms are associated with idiopathic premature ovarian failure.
    Bretherick KL; Hanna CW; Currie LM; Fluker MR; Hammond GL; Robinson WP
    Fertil Steril; 2008 Feb; 89(2):318-24. PubMed ID: 17706202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Androgen and reproductive physiology].
    Sueoka K
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():477-83. PubMed ID: 16689353
    [No Abstract]   [Full Text] [Related]  

  • 32. Phenotypic heterogeneity of mutations in androgen receptor gene.
    Rajender S; Singh L; Thangaraj K
    Asian J Androl; 2007 Mar; 9(2):147-79. PubMed ID: 17334586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
    Van Nieuwerburgh F; Stoop D; Cabri P; Dhont M; Deforce D; De Sutter P
    Gynecol Endocrinol; 2008 Dec; 24(12):669-73. PubMed ID: 19172534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure.
    Massin N; Méduri G; Bachelot A; Misrahi M; Kuttenn F; Touraine P
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):95-100. PubMed ID: 18191888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reproductive phenotype in polycystic ovary syndrome.
    Chang RJ
    Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):688-95. PubMed ID: 17893687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the development of selective androgen receptor modulators.
    Zhang X; Lanter JC; Sui Z
    Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro assessment of transcriptional activation of the estrogen and androgen receptors of mosquitofish, Gambusia affinis affinis.
    Katsu Y; Hinago M; Sone K; Urushitani H; Guillette LJ; Iguchi T
    Mol Cell Endocrinol; 2007 Sep; 276(1-2):10-7. PubMed ID: 17669586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian theca cell.
    Magoffin DA
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1344-9. PubMed ID: 15833266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular dysfunction induced by autoimmunity to zona pellucida.
    Koyama K; Hasegawa A; Mochida N; Calongos G
    Reprod Biol; 2005 Nov; 5(3):269-78. PubMed ID: 16372044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.